Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study)

^aFrom the Department of Radiology (K.R.M., J.R.F.), University of Washington Medical Center, Seattle, Washington
^bClinical Research Department (D.S.-J.), National Institute of Neurology and Neurosurgery, Mexico City, Mexico
^cDepartment of Radiology (S.J.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
^dUniversidad Autonoma de Nuevo Leon (G.E.-R.), Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Mexico
^eCentro Medico Imbanaco (W.E.), Cali, Colombia
^fDepartment of Radiology (A.B.), University of Alabama, Birmingham, Alabama
^gMedical University of South Carolina (D.R.R.), Charleston, South Carolina
^hGuerbet (J.H., C.P.), Roissy–Charles de Gaulle, France
ⁱDepartment of Radiology (A.J.T.), Weill Cornell Medical College, New York, New York
^jDepartment of Radiology (E.H.), University of Maryland, Baltimore, Maryland
^kCenter for Stroke Research Berlin (J.B.F.), Charité-Universitätsmedizin, Berlin, Germany.

Please address correspondence to Kenneth R. Maravilla, MD, Department of Radiology, University of Washington, 1959 NE Pacific, Box 357115, Seattle, WA 98195; e-mail: kmarav{at}uw.edu